- Oxaliplatin and capecitabine in the treatment of patients with recurrent or refractory carcinoma of unknown primary site: a phase 2 trial of the Sarah Cannon Oncology Research Consortium. Hainsworth, J.D., Spigel, D.R., Burris, H.A., Shipley, D., Farley, C., Macias-Perez, I.M., Barton, J., Greco, F.A. Cancer (2010)